58 related articles for article (PubMed ID: 22901144)
1. Differential distribution of miR-20a and miR-20b may underly metastatic heterogeneity of breast cancers.
Li JY; Zhang Y; Zhang WH; Jia S; Kang Y; Zhu XY
Asian Pac J Cancer Prev; 2012; 13(5):1901-6. PubMed ID: 22901144
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA expression as risk biomarker of breast cancer metastasis: a pilot retrospective case-cohort study.
Marino AL; Evangelista AF; Vieira RA; Macedo T; Kerr LM; Abrahão-Machado LF; Longatto-Filho A; Silveira HC; Marques MM
BMC Cancer; 2014 Oct; 14():739. PubMed ID: 25277099
[TBL] [Abstract][Full Text] [Related]
3. Integrated analysis of microRNA and mRNA expression and association with HIF binding reveals the complexity of microRNA expression regulation under hypoxia.
Camps C; Saini HK; Mole DR; Choudhry H; Reczko M; Guerra-Assunção JA; Tian YM; Buffa FM; Harris AL; Hatzigeorgiou AG; Enright AJ; Ragoussis J
Mol Cancer; 2014 Feb; 13():28. PubMed ID: 24517586
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-199a-5p is associated with hypoxia-inducible factor-1α expression in lungs from patients with COPD.
Mizuno S; Bogaard HJ; Gomez-Arroyo J; Alhussaini A; Kraskauskas D; Cool CD; Voelkel NF
Chest; 2012 Sep; 142(3):663-672. PubMed ID: 22383663
[TBL] [Abstract][Full Text] [Related]
5. Analysis of microRNA expression in rat kidneys after VEGF inhibitor treatment under different degrees of hypoxia.
Xu Y; Zhu Y; Xu J; Mao H; Li J; Zhu X; Kong X; Zhang J
Physiol Genomics; 2023 Nov; 55(11):504-516. PubMed ID: 37642276
[TBL] [Abstract][Full Text] [Related]
6. The potential mechanism of HIF-1α and CD147 in the development of triple-negative breast cancer.
Chen M; Liu Z; Zheng K; Hu C; Peng P
Medicine (Baltimore); 2024 Jun; 103(23):e38434. PubMed ID: 38847725
[TBL] [Abstract][Full Text] [Related]
7. The clinico-pathologic role of microRNAs miR-9 and miR-151-5p in breast cancer metastasis.
Krell J; Frampton AE; Jacob J; Pellegrino L; Roca-Alonso L; Zeloof D; Alifrangis C; Lewis JS; Jiao LR; Stebbing J; Castellano L
Mol Diagn Ther; 2012 Jun; 16(3):167-72. PubMed ID: 22489664
[TBL] [Abstract][Full Text] [Related]
8. MicroRNAs as biomarkers for breast cancer.
Canatan D; Sönmez Y; Yılmaz Ö; Çim A; Coşkun HŞ; Sezgin Göksu S; Ucar S; Aktekin MR
Acta Biomed; 2021 May; 92(2):e2021028. PubMed ID: 33988168
[TBL] [Abstract][Full Text] [Related]
9. The VEGF-Hypoxia Signature Is Upregulated in Basal-like Breast Tumors from Women of African Ancestry and Associated with Poor Outcomes in Breast Cancer.
Han YJ; Liu S; Hardeman A; Rajagopal PS; Mueller J; Khramtsova G; Sanni A; Ajani M; Clayton W; Hurley IW; Yoshimatsu TF; Zheng Y; Parker J; Perou CM; Olopade OI
Clin Cancer Res; 2024 Jun; 30(11):2609-2618. PubMed ID: 38564595
[TBL] [Abstract][Full Text] [Related]
10. Global microRNA profiling of well-differentiated small intestinal neuroendocrine tumors.
Li SC; Essaghir A; Martijn C; Lloyd RV; Demoulin JB; Oberg K; Giandomenico V
Mod Pathol; 2013 May; 26(5):685-96. PubMed ID: 23328977
[TBL] [Abstract][Full Text] [Related]
11. Predicting MicroRNA Biomarkers for Cancer Using Phylogenetic Tree and Microarray Analysis.
Wang H
Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27213352
[TBL] [Abstract][Full Text] [Related]
12. Inhibiting anti-angiogenic VEGF165b activates a miR-17-20a-Calcipressin-3 pathway that revascularizes ischemic muscle in peripheral artery disease.
Batan S; Kuppuswamy S; Wood M; Reddy M; Annex B; Ganta V
Commun Med (Lond); 2024 Jan; 4(1):3. PubMed ID: 38182796
[TBL] [Abstract][Full Text] [Related]
13. The effects of timing of fine needle aspiration biopsies on gene expression profiles in breast cancers.
Wong V; Wang DY; Warren K; Kulkarni S; Boerner S; Done SJ; Leong WL
BMC Cancer; 2008 Sep; 8():277. PubMed ID: 18826606
[TBL] [Abstract][Full Text] [Related]
14. Identification of miR-20a as A Potential Discerning Biomarker for Non-Invasive versus Invasive Retinoblastoma.
Bereimipour A; Karimi S; Faranoush M; Hedayati Asl AA; Miri MS; Satarian L; Taleahmad S
Cell J; 2024 May; 26(4):250-258. PubMed ID: 38736409
[TBL] [Abstract][Full Text] [Related]
15. Identification of MicroRNAs Associated with Histological Grade in Early-Stage Invasive Breast Cancer.
Kurozumi S; Seki N; Narusawa E; Honda C; Tokuda S; Nakazawa Y; Yokobori T; Katayama A; Mongan NP; Rakha EA; Oyama T; Fujii T; Shirabe K; Horiguchi J
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203206
[TBL] [Abstract][Full Text] [Related]
16. Aptamer/Peptide-Functionalized Nanoprobe for Detecting Multiple miRNAs in Circulating Malignant Cells to Study Tumor Heterogeneity.
Han D; Ren XH; He XY; Chen XS; Pang X; Cheng SX
ACS Biomater Sci Eng; 2023 Oct; 9(10):5832-5842. PubMed ID: 37679307
[TBL] [Abstract][Full Text] [Related]
17. Underexpression of miR-126 and miR-20b in hereditary and nonhereditary colorectal tumors.
Yamaguchi T; Iijima T; Wakaume R; Takahashi K; Matsumoto H; Nakano D; Nakayama Y; Mori T; Horiguchi S; Miyaki M
Oncology; 2014; 87(1):58-66. PubMed ID: 24994098
[TBL] [Abstract][Full Text] [Related]
18. miR-20b is up-regulated in brain metastases from primary breast cancers.
Ahmad A; Ginnebaugh KR; Sethi S; Chen W; Ali R; Mittal S; Sarkar FH
Oncotarget; 2015 May; 6(14):12188-95. PubMed ID: 25893380
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia-driven ncRNAs in breast cancer.
H Al-Zuaini H; Rafiq Zahid K; Xiao X; Raza U; Huang Q; Zeng T
Front Oncol; 2023; 13():1207253. PubMed ID: 37583933
[TBL] [Abstract][Full Text] [Related]
20. The Intricate Interplay between Cancer Stem Cells and Oncogenic miRNAs in Breast Cancer Progression and Metastasis.
Tsintarakis A; Papalouka C; Kontarini C; Zoumpourlis P; Karakostis K; Adamaki M; Zoumpourlis V
Life (Basel); 2023 Jun; 13(6):. PubMed ID: 37374142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
